Funded Tech Companies
Corsair Pharma
Headquartered in Sunnyvale, Corsair Pharma has funding from New Rhein Healthcare Investors, Junson Capital and Primavera Capital.
Company Overview
Company Name
Corsair Pharma
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1230 Bordeaux Drive
Sunnyvale, CA 94089
USA
Sunnyvale, CA 94089
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients. The company's first product candidate is a prodrug of treprostinil delivered on a proprietary transdermal patch to treat pulmonary arterial hypertension (PAH). Corsair also believes that their transdermal patch has the potential in other forms of pulmonary hypertension. The company has a strategic partnership with United Therapeutics, the market leader in PAH therapies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/21/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
President
Bobby Singh
Company Investors
- New Rhein Healthcare Investors
- Junson Capital
- Primavera Capital
- Plaisance Capital Management
- Midas Capital
Browse more funded tech companies:
Share this article
About Our Venture Capital Transactions Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs